Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Denali Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Denali Therapeutics Inc
Rating: 1.41841675
Author: Trendlyne DVM scores

about

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant...

19.23 -0.06 (-0.31%)

56.34% Gain from 52W Low

1.1M

XNAS Volume

XNAS 10 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.7 / 100

Technically Neutral

49.1 / 100

1Yr Price target upside is 102%

14 analysts

Denali Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant...

56.34% Gain from 52W Low

SWOT Analysis

Denali Therapeutics Inc Live Price Chart